Department of Psychological and Brain Sciences, Boston University, 64 Cummington Mall, Boston, MA, 02215, USA.
Department of Genetics, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA, USA.
Psychopharmacology (Berl). 2020 Sep;237(9):2633-2648. doi: 10.1007/s00213-020-05560-6. Epub 2020 Jun 3.
We probed serotonin neurons, those denoted by their developmental gene expression as r2Hoxa2-Pet1 (experiment 1) and Drd1a-Pet1 (experiment 2), for differential modulation of cocaine reward and memory as revealed by the expression and development of conditioned place preference (CPP) in transgenic mice.
To query roles in CPP, we inhibited neurons cell autonomously in vivo by activating the transgenically expressed, synthetic DREADD receptor hMDi (Di) with the exogenous ligand clozapine-N-oxide (CNO).
To examine CPP expression, mice were conditioned using behaviorally active doses of cocaine (10.0 or 17.8 mg/kg) vs. saline followed by CPP assessment, first without neuron inhibition (post-conditioning session 1), and then with CNO-mediated neuron inhibition (post-conditioning session 2), followed by 4 more post-conditioning sessions. To examine CPP development, we administered CNO during conditioning sessions and then assayed CPP across 6 post-conditioning sessions.
In r2Hoxa2-Pet1-Di mice, post-conditioning CNO administration did not impact cocaine CPP expression, but after CNO administration during conditioning, cocaine CPP (17.8 mg/kg) persisted across post-conditioning sessions compared with that in controls, suggesting a deficit in extinguishing cocaine memory. Drd1a-Pet1-Di mice, prior to CNO-Di-triggered neuronal inhibition, unexpectedly expressed heightened cocaine CPP (10.0 and 17.8 mg/kg) compared with controls, and this basal phenotype was transiently blocked by acute post-conditioning CNO administration and persistently blocked by repeated CNO administration during conditioning.
Cocaine reward and memory likely map to distinct serotonergic Pet1 neuron subtypes. r2Hoxa2-Pet1 neurons normally may limit the durability of cocaine memory, without impacting initial cocaine reward magnitude. Drd1a-Pet1 neurons normally may help to promote cocaine reward.
我们探测了血清素神经元,这些神经元通过其发育基因表达来表示,例如 r2Hoxa2-Pet1(实验 1)和 Drd1a-Pet1(实验 2),以研究可卡因奖赏和记忆的差异调节,这种调节是通过转基因小鼠条件性位置偏好(CPP)的表达和发展来揭示的。
为了探究 CPP 中的作用,我们通过激活转基因表达的合成 DREADD 受体 hMDi(Di),用外源性配体氯氮平-N-氧化物(CNO),在体内自主抑制神经元。
为了研究 CPP 的表达,我们使用行为活性剂量的可卡因(10.0 或 17.8 mg/kg)对小鼠进行条件作用,然后用盐水进行 CPP 评估,首先在没有神经元抑制的情况下(后条件作用 1 期),然后用 CNO 介导的神经元抑制(后条件作用 2 期),然后再进行 4 次后条件作用。为了研究 CPP 的发展,我们在条件作用期间给予 CNO,然后在 6 次后条件作用期间检测 CPP。
在 r2Hoxa2-Pet1-Di 小鼠中,后条件 CNO 给药不会影响可卡因 CPP 的表达,但在条件作用期间给予 CNO 后,与对照组相比,可卡因 CPP(17.8 mg/kg)持续存在于后条件作用期间,表明可卡因记忆的消退存在缺陷。Drd1a-Pet1-Di 小鼠在 CNO-Di 触发神经元抑制之前,出乎意料地表现出可卡因 CPP(10.0 和 17.8 mg/kg)的升高,与对照组相比,这种基础表型被急性后条件 CNO 给药短暂阻断,在条件作用期间重复给予 CNO 持续阻断。
可卡因奖赏和记忆可能映射到不同的血清素 Pet1 神经元亚型。r2Hoxa2-Pet1 神经元通常可能限制可卡因记忆的持久性,而不影响初始可卡因奖赏的大小。Drd1a-Pet1 神经元通常可能有助于促进可卡因奖赏。